André Siqueira

André Siqueira joined DNDi in July 2024 as Head of Dengue Global Programme.

André has worked in clinical research for the past 15 years, focusing on acute febrile illnesses such as malaria, dengue and chikungunya. He has designed and conducted several observational and intervention studies for the prevention and treatment of these diseases and was part of the team that described the risk of microcephaly in foetuses of pregnant women infected with Zika. He is also one of the Principal Investigators for Butantan’s dengue vaccine clinical trial and founded/coordinated the Chikungunya Clinical and Applied Research Network (REPLICK).

He is a member of several national and international advisory committees, including CEPI’s Scientific Advisory Committee and Brazil’s National Malaria and Arbovirus Programmes, involved in drafting the most recent versions of the Clinical Management Guidelines for Malaria, Chikungunya and Dengue for the Ministry of Health.